DK2003130T3 - Nyt pyridinderivat med anti-helicobacter pylori-aktivitet - Google Patents

Nyt pyridinderivat med anti-helicobacter pylori-aktivitet

Info

Publication number
DK2003130T3
DK2003130T3 DK07715278.3T DK07715278T DK2003130T3 DK 2003130 T3 DK2003130 T3 DK 2003130T3 DK 07715278 T DK07715278 T DK 07715278T DK 2003130 T3 DK2003130 T3 DK 2003130T3
Authority
DK
Denmark
Prior art keywords
gastric
pyridine derivative
helicobacter pylori
pyroli
pylori activity
Prior art date
Application number
DK07715278.3T
Other languages
English (en)
Inventor
Masaharu Ito
Masaichi Yamamoto
Original Assignee
Arigen Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arigen Pharmaceuticals Inc filed Critical Arigen Pharmaceuticals Inc
Application granted granted Critical
Publication of DK2003130T3 publication Critical patent/DK2003130T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK07715278.3T 2006-03-10 2007-03-07 Nyt pyridinderivat med anti-helicobacter pylori-aktivitet DK2003130T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006066431 2006-03-10
PCT/JP2007/054387 WO2007105551A1 (ja) 2006-03-10 2007-03-07 抗ヘリコバクター・ピロリ作用を有する新規ピリジン誘導体

Publications (1)

Publication Number Publication Date
DK2003130T3 true DK2003130T3 (da) 2011-12-12

Family

ID=38509384

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07715278.3T DK2003130T3 (da) 2006-03-10 2007-03-07 Nyt pyridinderivat med anti-helicobacter pylori-aktivitet

Country Status (17)

Country Link
US (1) US20090143438A1 (da)
EP (1) EP2003130B1 (da)
JP (1) JP5053992B2 (da)
KR (1) KR101348643B1 (da)
CN (1) CN101400670B (da)
AT (1) ATE533757T1 (da)
AU (1) AU2007225935B2 (da)
BR (1) BRPI0708601A2 (da)
CA (1) CA2645467C (da)
DK (1) DK2003130T3 (da)
ES (1) ES2374730T3 (da)
MX (1) MX2008011594A (da)
PL (1) PL2003130T3 (da)
PT (1) PT2003130E (da)
RU (1) RU2433126C2 (da)
SI (1) SI2003130T1 (da)
WO (1) WO2007105551A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102001024B1 (ko) 2017-09-29 2019-07-17 서울프로폴리스 주식회사 프로폴리스를 포함하는, 위염 및 헬리코박터 파일로리 억제를 위한 조성물
KR102041615B1 (ko) 2017-09-29 2019-11-06 서울프로폴리스 주식회사 원산지가 다른 프로폴리스 추출물을 혼합 사용하는 프로폴리스의 사용방법 및 프로폴리스를 유효성분으로 하는 건강기능식품용 조성물

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
ZA825106B (en) 1981-08-13 1983-04-27 Haessle Ab Novel pharmaceutical compositions
ZW4585A1 (en) * 1984-04-19 1985-11-20 Hoffmann La Roche Imidazole derivatives
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS6150979A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
JPH0674272B2 (ja) * 1986-11-13 1994-09-21 エーザイ株式会社 ピリジン誘導体及びそれを含有する潰瘍治療剤
JP2694361B2 (ja) 1989-02-09 1997-12-24 アストラ アクチエボラグ 抗菌剤
JPH0720865B2 (ja) * 1989-02-10 1995-03-08 武田薬品工業株式会社 抗菌剤
DK0382489T3 (da) * 1989-02-10 1995-01-16 Takeda Chemical Industries Ltd Monoklonalt anti-humant papillomvirusantistof, hybridomcelle, der producerer dette, samt fremgangsmåde til fremstilling deraf
JPH0348680A (ja) 1989-07-18 1991-03-01 Yoshitomi Pharmaceut Ind Ltd 抗菌剤
JP2798588B2 (ja) 1992-08-21 1998-09-17 エーザイ株式会社 抗菌剤
EP0642797B1 (en) * 1993-09-09 2000-05-17 Takeda Chemical Industries, Ltd. Formulation comprising antibacterial substance and antiulcer substance
JPH07126189A (ja) * 1993-09-09 1995-05-16 Takeda Chem Ind Ltd 抗潰瘍併用療法用製剤
CN1157610A (zh) * 1994-07-20 1997-08-20 比克·古尔顿·劳姆贝尔格化学公司 抗螺杆菌的吡啶基硫基化合物
DE69519581T2 (de) 1994-08-30 2001-05-31 Teikoku Chemical Industry Co., Ltd. Guanidylmethyl cyclohexancarbonsäure ester derivate
CN1205632A (zh) * 1995-12-22 1999-01-20 帝国化学产业株式会社 抗幽门螺杆菌剂
US6444703B1 (en) * 1995-12-22 2002-09-03 Teikoku Chemical Industries Co., Ltd. Cyclohexane carbocyclic ester derivative and cyclodextrin complex and composition for treatment of helicobacter pylori infections
ES2171116B1 (es) * 2000-04-14 2003-08-01 Esteve Quimica Sa Procedimiento para la obtencion de derivados de (((piridil sustituido)metil)tio)bencimidazol.
JP4490765B2 (ja) 2004-08-24 2010-06-30 株式会社東芝 熱−電気直接変換装置

Also Published As

Publication number Publication date
PT2003130E (pt) 2012-01-10
CA2645467A1 (en) 2007-09-20
KR101348643B1 (ko) 2014-01-08
CA2645467C (en) 2012-04-24
BRPI0708601A2 (pt) 2011-06-07
EP2003130A4 (en) 2010-12-22
HK1122290A1 (en) 2009-05-15
JPWO2007105551A1 (ja) 2009-07-30
AU2007225935A1 (en) 2007-09-20
CN101400670A (zh) 2009-04-01
EP2003130A2 (en) 2008-12-17
ES2374730T3 (es) 2012-02-21
CN101400670B (zh) 2012-10-10
US20090143438A1 (en) 2009-06-04
RU2433126C2 (ru) 2011-11-10
EP2003130A9 (en) 2009-04-15
SI2003130T1 (sl) 2012-02-29
JP5053992B2 (ja) 2012-10-24
KR20090005292A (ko) 2009-01-13
ATE533757T1 (de) 2011-12-15
AU2007225935B2 (en) 2011-12-22
PL2003130T3 (pl) 2012-04-30
WO2007105551A1 (ja) 2007-09-20
EP2003130B1 (en) 2011-11-16
MX2008011594A (es) 2008-09-22
RU2008140164A (ru) 2010-04-20

Similar Documents

Publication Publication Date Title
TW200833675A (en) Nicotinamide derivatives
DK1539700T3 (da) 8-hydroxyquinolin-derivater
NO20065494L (no) Fuserte kinolinderivater og anvendelse derav
WO2007095174A3 (en) Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated diseases or conditions
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
MX2009004096A (es) Metabolitos de talarozol.
WO2007009656A3 (de) Neues 1,4-benzothiazepin-1,1-dioxidderivat mit verbesserten eigenschaften, verfahren zu dessen herstellung, diese verbindung enthaltende arzneimittel und dessen verwendung
TW200728307A (en) Novel spirochromanone derivatives
WO2008019967A3 (en) Phenyl, pyridine and quinoline derivatives
WO2008076270A3 (en) Sulfide, sulfoxide and sulfone chalcone analogues, derivatives thereof and therapeutic uses thereof
ATE307810T1 (de) Imidazol-2-carbonsäureamid derivate als raf- kinase-inhibitoren
RU2009102243A (ru) Производные камптотецина с противоопухолевой активностью
CA2671949A1 (en) Helicobacter pylori eradicating agent having inhibitory activity on gastric acid secretion
BRPI0409627A (pt) 2-hidróxi-3-diaminoalcanos de fenacila
BR0305708A (pt) Derivados de benzimidazol para o tratamento de disfunção sexual
BRPI0412636A (pt) imidazopirimidinas substituìdas para a prevenção e tratamento de cáncer
DK1262181T3 (da) Brug af isothiazolderivater som ureasehæmmere for behandling af gastrointestinale sygdomme forårsaget af Heliobacter pylori
TW200716650A (en) Thienopyridine derivative, or quinoline derivative, or quinazoline derivative, having c-met autophosphorylation inhibiting potency
UA96969C2 (en) Acylaminopyrazoles as fgfr inhibitors
EA200970555A1 (ru) Трициклическое соединение и его медицинское применение
DK2003130T3 (da) Nyt pyridinderivat med anti-helicobacter pylori-aktivitet
EP1861391A4 (en) SUBSTITUTED SULFOXIDE COMPOSITIONS, METHOD FOR THE PRODUCTION THEREOF AND THE USE THEREOF
JP2006524208A5 (da)
TNSN07116A1 (fr) Nouveaux sels de strontium d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
BRPI0807799A2 (pt) " derivados de 2-piperazin-1-il-3h-imidazo{4,5-b]piridina".